Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma

Published:2012-04-15 Issue:5 Volume:59 Page:447-454
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Krown Susan E.,Roy Debasmita,Lee Jeannette Y.,Dezube Bruce J.,Reid Erin G.,Venkataramanan Raman,Han Kelong,Cesarman Ethel,Dittmer Dirk P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference36 articles.

1. . Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.;Hudes;N Engl J Med,2007

2. . Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors.;Motzer;Cancer,2010

3. . Phase III study to evaluate temsirolimus compared with investigators choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.;Hess;J Clin Oncol,2009

4. . Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.;Yao;J Clin Oncol,2010

5. . Cancer burden in the HIV-infected population in the United States.;Shiels;J Natl Cancer Inst,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice;Cell Host & Microbe;2024-05

2. Kaposi sarcoma-induced immune reconstitution syndrome: a case report;Annals of Medicine & Surgery;2024-03-15

3. Cancer and HIV: The Molecular Mechanisms of the Deadly Duo;Cancers;2024-01-26

4. Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?;Journal of Medical Virology;2023-05

5. Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19;Therapeutic Drug Monitoring;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3